C. Michael Gibson, MS, MD.

Professor of Medicine at Harvard Medical School

Medical Advisor at imaware™

Experience

Dr C. Michael Gibson, M.S., M.D. is an interventional cardiologist, cardiovascular researcher and educator who pioneered our understanding of the "open artery hypothesis" as well our understanding of the importance of restoring flow downstream in the capillary bed in the "open microvasculature hypothesis" in heart attack. Gibson has been a leading investigator in trials of thrombolytic agents, glycoprotein 2b3a inhibitor agents, thienopyridines, factor Xa inhibitors, lipid lowering agents and new devices. Gibson was named one of the world's most widely published and cited scientists of past decade in 2014 by Thomson Reuters.

Education

Dr. Gibson received his B.S., M.S., and M.D. degrees from the University of Chicago. He was an Intern, Resident and Chief Resident at the Brigham and Women’s Hospital, Harvard Medical School. He received his training as an interventional cardiologist and served as the Director of the Coronary Care Unit at Beth Israel Hospital, Harvard Medical School.

View Google Scholar profile

Expertise

  • Acute Coronary Syndrome Research Including unstable angina, non ST elevation MI and ST elevation M
  • Antiplatelet Trials
  • Antithrombin Trials
  • Reperfusion Injury Trials
  • Lipid Lowering and Atherosclerosis Regression Trials
  • New Device Trials
  • CMR Core Laboratory Trials
  • CT Angiographic Core Laboratory Trials
  • Coronary Artery Bypass Graft Trials
  • New Electrocardiography Technology Trials
  • Angiogenesis Trials
  • Stem Cell Therapy
  • NIH Studies
  • Diabetes
C. Michael Gibson, MS, MD.

Recommended By

C. Michael Gibson, MS, MD.

No items found.

Articles Medically Reviewed By

C. Michael Gibson, MS, MD.

No items found.

Articles Written By

C. Michael Gibson, MS, MD.

No items found.
Our content process